Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) have emerged as
potential drug delivery systems for various applications that are produced from …

Introduction From a biopharmaceutical standpoint, the skin is recognized as an interesting
route for drug delivery. In general, small molecules are able to penetrate the stratum …

In 1990, the lipid nanoparticles were invented in the laboratories, the first patent filings took
place in 1991. The lipid nanoparticles were developed as alternative to traditional carriers …

The high incidence of fungal infections has become a worrisome public health issue, having
been aggravated by an increase in host predisposition factors. Despite all the drugs …

Solid lipid nanoparticles (SLNs) are a well-tolerated lipid carrier system due to the
employment of a physiological and/or biodegradable lipid matrix. Physicochemical …

Hydrogels, composed of hydrophilic polymer networks, have emerged as versatile materials
in biomedical applications due to their high water content, biocompatibility, and tunable …

The development of novel antifungal agents and, in particular, the widespread use of these
medications over the course of the past two decades, has had a significant impact on the …

Lipids and lipid nanoparticles are extensively employed as oral‐delivery systems for drugs
and other active ingredients. These have been exploited for many features in the field of …

Invasive fungal infections are becoming a major health concern in several groups of patients
leading to severe morbidity and mortality. Moreover, cutaneous fungal infections are a major …

Recent advances in the field of nanotechnology have allowed the manufacturing of
elaborated nanometer-sized particles for various biomedical applications. A broad spectrum …